Skip to main content

. 2021 Jun 15;131(12):e151719. doi: 10.1172/JCI151719

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Michael D Nyquist, Lisa S Ang, Alexandra Corella, Ilsa M Coleman, Michael P Meers, Anthony J Christiani, Cordell Pierce, Derek H Janssens, Hannah E Meade, Arnab Bose, Lauren Brady, Timothy Howard, Navonil De Sarkar, Sander B Frank, Ruth F Dumpit, James T Dalton, Eva Corey, Stephen R Plymate, Michael C Haffner, Elahe A Mostaghel, Peter S Nelson

PMCID: PMC8203444 PMID: 34128479

Original citation: J Clin Invest. 2021;131(10):e146777. https://doi.org/10.1172/JCI146777

Citation for this corrigendum: J Clin Invest. 2021;131(12):e151719. https://doi.org/10.1172/JCI151719

The heatmap shown in Figure 2A was incorrect. The correct figure part is below. The manuscript has been corrected online.

The authors regret the error.

graphic file with name jci-131-151719-i267.jpg

Version 1. 06/15/2021

Electronic publication

Footnotes

See the related article at Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.

ACTIONS

RESOURCES